"On behalf of Thairm Bio, I am proud to support Phlo and personally excited to see what the team achieves in the next stage of their journey.” Thairm Bio founder Mark Bamforth said Phlo heralded a step change in patient access and healthcare outcomes, coming at a "pivotal moment" for the industry.īamforth added: "Phlo’s dedication to building innovative digital solutions that put patients and clinicians at the heart of what they do is key to driving positive change in the sector, empowering patients and healthcare providers. Babylon, the digital doctor's surgery, has already signed up as have fellow e-health players SkinDoc, Syrona Health and Dermatology Partnership. It's a crucial piece of the puzzle as far as the UK's digital health space is concerned, allowing non-physical clinics to integrate pharmacy services with their existing digital offerings. With its Phlo Connect platform, it wants also to provide digital pharmacy infrastructure for third parties. The platform launched in 2020 and so far has processed more than 110,000 orders. Given competition to reach more UK markets, Phlo will utilise the series A cash to scale operationally, principally striking up more partnership deals with healthcare providers. Availability in another major UK city, Manchester, is anticipated later this year. Phlo Digital Pharmacy is already live in Birmingham and London. The series A round is led by family office Thairm Bio, with support from government-owned investor Scottish Enterprise, together with a roster of "high-profile" business angels. Days after first mover advantage was declared by UK-based startup Healistic, a London/Glasgow competitor has crowded in on its hype by disclosing a £10 million series A round for its same-day platform, Phlo Digital Pharmacy, also billed as first in category. Looks like UK same-day pharmacy delivery is catching heat.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |